Meiling Yan

1.1k total citations · 1 hit paper
42 papers, 808 citations indexed

About

Meiling Yan is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Meiling Yan has authored 42 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Immunology. Recurrent topics in Meiling Yan's work include Inflammasome and immune disorders (7 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Meiling Yan is often cited by papers focused on Inflammasome and immune disorders (7 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Meiling Yan collaborates with scholars based in China, United States and Hong Kong. Meiling Yan's co-authors include Jawahar L. Mehta, Hongtao Diao, Chang-Ping Hu, Xiaoqi Shao, Xianglu Rong, Jiao Guo, Wenyi Wang, Dong Huang, Dongwei Wang and Weifang Zhang and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Neuroscience.

In The Last Decade

Meiling Yan

41 papers receiving 801 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial damage and activation of the cytosolic DNA sensor cGAS–STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice

2022 160 citations Meiling Yan, Yun Li et al. Cell Death Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meiling Yan China	16	466	202	160	151	101	42	808
Xiaoguang Zhu China	17	446 1.0×	163 0.8×	120 0.8×	175 1.2×	66 0.7×	31	839
Chunpeng Zou China	14	310 0.7×	147 0.7×	211 1.3×	75 0.5×	92 0.9×	35	799
Jingti Deng China	16	434 0.9×	103 0.5×	98 0.6×	157 1.0×	82 0.8×	31	767
Xiaohu Chen China	14	429 0.9×	84 0.4×	114 0.7×	136 0.9×	93 0.9×	48	808
Prakash Doddapattar United States	22	352 0.8×	318 1.6×	119 0.7×	136 0.9×	112 1.1×	33	976
Sijia Liang China	15	430 0.9×	114 0.6×	67 0.4×	180 1.2×	69 0.7×	32	754
Zhen Qiu China	14	784 1.7×	165 0.8×	125 0.8×	195 1.3×	146 1.4×	38	1.2k
Yunfei Bian China	15	258 0.6×	102 0.5×	198 1.2×	121 0.8×	86 0.9×	38	644
Chuan Qiu United States	20	602 1.3×	129 0.6×	158 1.0×	100 0.7×	112 1.1×	66	1.2k

Countries citing papers authored by Meiling Yan

Since Specialization

Citations

This map shows the geographic impact of Meiling Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Yan more than expected).

Fields of papers citing papers by Meiling Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiling Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Yan. The network helps show where Meiling Yan may publish in the future.

Co-authorship network of co-authors of Meiling Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Meiling Yan. A scholar is included among the top collaborators of Meiling Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiling Yan. Meiling Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Xiao, et al.. (2025). The role of the gut microbiota and its metabolites: a new predictor in diabetes and its complications. European journal of medical research. 30(1). 601–601.

Zhang, Xi, et al.. (2025). Targeting the cGAS-STING Pathway to Modulate Immune Inflammation in Diabetes and Cardiovascular Complications: Mechanisms and Therapeutic Insights. Current Issues in Molecular Biology. 47(9). 750–750. 1 indexed citations

Yan, Meiling, et al.. (2024). Semaglutide attenuates pathological electrophysiological remodeling in diabetic cardiomyopathy via restoring Cx43 expression. Endocrine. 84(3). 969–979. 7 indexed citations

Yan, Meiling, Zhou Liu, Wenru Zeng, et al.. (2024). USP7 promotes cardiometabolic disorders and mitochondrial homeostasis dysfunction in diabetic mice via stabilizing PGC1β. Pharmacological Research. 205. 107235–107235. 10 indexed citations

Diao, Hongtao, et al.. (2023). The m6A Reader YTHDF1 Promotes Lung Carcinoma Progression via Regulating Ferritin Mediate Ferroptosis in an m6A-Dependent Manner. Pharmaceuticals. 16(2). 185–185. 13 indexed citations

Zhang, Xinran, Yun Liu, Yuanyuan Guo, et al.. (2023). Phosphorylation of RasGRP1 by Shc3 prevents RasGRP1 degradation and contributes to Ras/c-Jun activation in hepatocellular carcinoma. Molecular and Cellular Biochemistry. 479(9). 2307–2321. 5 indexed citations

Xu, Qian, Meiling Yan, & Yaoliang Tang. (2023). 3D-Autologous Culture Method for Precision Oncology. Methods in molecular biology. 2660. 61–68. 1 indexed citations

Shao, Xiaoqi, et al.. (2022). The Traditional Chinese Medicine Formula FTZ Protects against Cardiac Fibrosis by Suppressing the TGFβ1-Smad2/3 Pathway. Evidence-based Complementary and Alternative Medicine. 2022. 1–11. 3 indexed citations

Shao, Xiaoqi, Xueying Huang, Hongtao Diao, et al.. (2022). Fu Fang Zhen Zhu Tiao Zhi Capsules Protect against Myocardial Ischemia by Inhibiting Cardiomyocyte Pyroptosis. Evidence-based Complementary and Alternative Medicine. 2022. 1–15. 3 indexed citations

10.

Yan, Meiling, Yun Li, Wenru Zeng, et al.. (2022). Mitochondrial damage and activation of the cytosolic DNA sensor cGAS–STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice. Cell Death Discovery. 8(1). 258–258. 160 indexed citations breakdown →

11.

Liu, Peifang, Hui Li, Yueqiu Wang, et al.. (2020). Harmine Ameliorates Cognitive Impairment by Inhibiting NLRP3 Inflammasome Activation and Enhancing the BDNF/TrkB Signaling Pathway in STZ-Induced Diabetic Rats. Frontiers in Pharmacology. 11. 535–535. 30 indexed citations

12.

Wang, Wenyi, et al.. (2019). Circulating microRNA-92a level predicts acute coronary syndrome in diabetic patients with coronary heart disease. Lipids in Health and Disease. 18(1). 22–22. 30 indexed citations

13.

Yang, Lin, Jing Zhao, Yang Qu, et al.. (2019). Metoprolol prevents neuronal dendrite remodeling in a canine model of chronic obstructive sleep apnea. Acta Pharmacologica Sinica. 41(5). 620–628. 9 indexed citations

14.

Huang, Dong, Meiling Yan, Penglong Wu, et al.. (2018). Cardiac-Specific Overexpression of Silent Information Regulator 1 Protects Against Heart and Kidney Deterioration in Cardiorenal Syndrome via Inhibition of Endoplasmic Reticulum Stress. Cellular Physiology and Biochemistry. 46(1). 9–22. 12 indexed citations

15.

Wang, Wenyi, et al.. (2018). Exosomes derived miR-126 attenuates oxidative stress and apoptosis from ischemia and reperfusion injury by targeting ERRFI1. Gene. 690. 75–80. 48 indexed citations

16.

Wang, Wenyi, et al.. (2018). MiRNA-92a protects pancreatic B-cell function by targeting KLF2 in diabetes mellitus. Biochemical and Biophysical Research Communications. 500(3). 577–582. 26 indexed citations

17.

Huang, Dong, Ming Guo, Shuai Li, et al.. (2014). Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats. International Journal of Molecular Medicine. 35(3). 829–838. 11 indexed citations

18.

Huang, Dong, Wei Zhu, Shuai Li, et al.. (2013). Selective inhibition of PKCβ2 preserves cardiac function after myocardial infarction and is associated with improved angiogenesis of ischemic myocardium in diabetic rats. International Journal of Molecular Medicine. 32(5). 1037–1046. 11 indexed citations

19.

Luo, Ping, Meiling Yan, Edward D. Fröhlich, Jawahar L. Mehta, & Chang-Ping Hu. (2011). Novel Concepts in the Genesis of Hypertension: Role of LOX-1. Cardiovascular Drugs and Therapy. 25(5). 441–449. 23 indexed citations

20.

Yan, Meiling, Jawahar L. Mehta, Weifang Zhang, & Chang‐Ping Hu. (2011). LOX-1, Oxidative Stress and Inflammation: A Novel Mechanism for Diabetic Cardiovascular Complications. Cardiovascular Drugs and Therapy. 25(5). 451–459. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact